Reasons to Work with CCRM Australia

 

The CCRM partner network represents key sectors of the Regenerative Medicine (RM) industry – pharmaceutical, devices, reagents, tools, biomaterials and cell therapies and consists of large multinationals, small-medium enterprises (SME) and emerging biotechnology companies. It provides market knowledge and a ready supply of global receptors for technologies and products generated by CCRM and its partners. The benefits of Australian companies becoming a member of the Industry consortium include:

  • Increased brand recognition and awareness

  • Access to potential customers at an international level

  • Access to Intellectual Property (IP)

  • Thought leadership

  • Collaborative development and advancement of project ideas, and

  • Increased engagement with the broader regenerative medicine community

  • Product development team to augment academic expertise and facilities

  • International industry consortium that reconciles technology push with market pull

  • Network of local and international business and scientific leaders

 

Being part of CCRM Australia offers:

  • For Industry: Access to state-of-art discoveries, facilities and expertise in Australia and through the CCRM global network. Access to clinical trial networks.

  • For Academics: Business leaders and corporate partners to accelerate commercialization drawn from an international pool

  • For Investors: risk-mitigated and capital-efficient product development

 

Resources

To learn more about CCRM Australia:

CCRM Australia Solutions

For Universities

To learn about benefits for Universities:

University benefits with CCRM Australia